Top compounds associated with response to DYTN


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA bendamustine CTRPv2 pan-cancer AAC -0.058 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA RITA CTRPv2 pan-cancer AAC 0.054 0.1
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.053 0.1
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA FMK GDSC1000 pan-cancer AAC 0.057 0.1
mRNA importazole CTRPv2 pan-cancer AAC 0.057 0.1
mRNA BMS-509744 GDSC1000 pan-cancer AAC -0.079 0.1
Download CSV